Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 1/20 | 0.52 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.52 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.52 |
| ▸ | CYP2C9 | P11712 | 3/20 | 0.51 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.49 |
| ▸ | LMNA | P02545 | 1/20 | 0.49 |
| ▸ | MAPT | P10636 | 1/20 | 0.49 |
| ▸ | ESR2 | Q92731 | 5/20 | 0.41 |
| ▸ | P2RY6 | Q15077 | 1/20 | 0.40 |
| ▸ | ESR1 | P03372 | 3/20 | 0.36 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.36 |
| ▸ | MIF | P14174 | 1/20 | 0.35 |
| ▸ | NOS3 | P29474 | 2/20 | 0.34 |
| ▸ | NOS1 | P29475 | 2/20 | 0.34 |
| ▸ | NOS2 | P35228 | 2/20 | 0.34 |
| ▸ | SPHK1 | Q9NYA1 | 1/20 | 0.33 |
| ▸ | CHEK2 | O96017 | 1/20 | 0.33 |
| ▸ | DRD2 | P14416 | 1/20 | 0.33 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1457321 | 1.00 | MEN1 (0.52) | MEN1MAPK1KMT2ACYP2C9ALDH1A1 | |
| SCHEMBL10348069 | 0.98 | MEN1 (0.51) | MEN1MAPK1KMT2ACYP2C9ALDH1A1 | |
| SCHEMBL10348049 | 0.96 | MEN1 (0.49) | MEN1MAPK1KMT2ACYP2C9ALDH1A1 | |
| SCHEMBL10417322 | 0.96 | MEN1 (0.49) | MEN1MAPK1KMT2ACYP2C9ALDH1A1 | |
| SCHEMBL10532002 | 0.96 | MEN1 (0.49) | MEN1MAPK1KMT2ACYP2C9ALDH1A1 | |
| SCHEMBL10531997 | 0.96 | MEN1 (0.49) | MEN1MAPK1KMT2ACYP2C9ALDH1A1 | |
| SCHEMBL10347974 | 0.96 | MEN1 (0.49) | MEN1MAPK1KMT2ACYP2C9ALDH1A1 | |
| SCHEMBL10348559 | 0.96 | MEN1 (0.49) | MEN1MAPK1KMT2ACYP2C9ALDH1A1 | |
| SCHEMBL10347893 | 0.93 | P2RY6 (0.53) | MEN1MAPK1KMT2ACYP2C9ALDH1A1 | |
| SCHEMBL10347892 | 0.93 | P2RY6 (0.53) | MEN1MAPK1KMT2ACYP2C9ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 105 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20060241178-A1 | Compositions and methods for treating lung cancer | IMMUNEGUARD LLC (US) | 2006-10-26 | — | — | US | claimed |
| US-20010044012-A1 | Transparent substrate between a hydrophilic ink receiving layer and a colored hydrophobic luminescent layer; creating photographic quality prints | XEROX CORPORATION | 2001-11-22 | — | — | US | claimed |
| US-6319591-B1 | Ink jet recording substrates | XEROX CORPORATION | 2001-11-20 | — | — | US | claimed |
| EP-0743574-B1 | Migration imaging members | XEROX CORP (US) | 2000-12-27 | — | — | EP | claimed |
| EP-0743573-B1 | Method for obtaining image contrast migration imaging members | XEROX CORP (US) | 2000-09-06 | — | — | EP | claimed |
| US-5846637-A | Coated xerographic photographic paper | XEROX CORPORATION (US) | 1998-12-08 | — | — | US | claimed |
| EP-0743574-A2 | Migration imaging members | XEROX CORPORATION (US) | 1996-11-20 | — | — | EP | claimed |
| EP-0743573-A2 | Method for obtaining image contrast migration imaging members | XEROX CORPORATION (US) | 1996-11-20 | — | — | EP | claimed |
| US-5563014-A | SOFTENABLE LAYER CONTAINIG PHOTOSENSITIVE MARKING MATERIAL; TRANSPARENTIZING AGENT | XEROX CORPORATION (US) | 1996-10-08 | — | — | US | claimed |
| US-5514505-A | SELECTIVE TRANSPARENTIZATION OF PHOTOSENSITIVE MIGRATION MARKING PARTICLES EMBEDDED NEAR THE SURFACE OF A SOFTENABLE LAYER SUPPORTED BY AN ELECTROCONDUCTIVE SUBSTRATE | XEROX CORPORATION (US) | 1996-05-07 | — | — | US | claimed |
| EP-0227004-B1 | LIQUID CRYSTALLINE ETHANE DERIVATIVES, THEIR PREPARATION AND THE LIQUID CRYSTAL COMPOSITIONS CONTAINING SAME | Wojskowa Akademia Techniczna im. Jaroslawa Dabrowskiego (PL) | 1990-04-11 | — | — | EP | claimed |
| EP-0126883-B1 | LIQUID CRYSTALLINE CYCLOHEXYLBENZENE DERIVATIVES, THEIR PREPARATION AND THE LIQUID CRYSTAL COMPOSITIONS CONTAINING THEM | Wojskowa Akademia Techniczna im. Jaroslawa Dabrowskiego (PL) | 1987-03-11 | — | — | EP | claimed |
| US-20240190866-A1 | POLYHYDROXYLATED INDOLIZIDINE AND PYRROLIZIDINE DERIVATIVES AND USES THEREOF | ACADEMIA SINICA (TW) | 2024-06-13 | — | — | US | disclosed |
| EP-4308108-A1 | POLYHYDROXYLATED INDOLIZIDINE AND PYRROLIZIDINE DERIVATIVES AND USES THEREOF | Academia Sinica (TW) | 2024-01-24 | — | — | EP | disclosed |
| WO-2022197564-A1 | POLYHYDROXYLATED INDOLIZIDINE AND PYRROLIZIDINE DERIVATIVES AND USES THEREOF | ACADEMIA SINICA (TW) | 2022-09-22 | — | — | WO | disclosed |
| EP-3470496-A1 | SPECTACLES WITH REMOTELY ACTIVATABLE DARKENING | Lapanik, Valeri I. (BY) | 2019-04-17 | — | — | EP | disclosed |
| EP-0126883-B1 | LIQUID CRYSTALLINE CYCLOHEXYLBENZENE DERIVATIVES, THEIR PREPARATION AND THE LIQUID CRYSTAL COMPOSITIONS CONTAINING THEM | Wojskowa Akademia Techniczna im. Jaroslawa Dabrowskiego (PL) | 1987-03-11 | — | — | EP | disclosed |
| WO-1986005799-A1 | LIQUID CRYSTAL PHASE | MERCK Patent Gesellschaft mit beschränkter Haftung (DE) | 1986-10-09 | — | — | WO | disclosed |
| EP-0170082-A2 | Liquid crystalline isothiocyanates with a dioxane ring and liquid crystalline admixtures containing the same | Wojskowa Akademia Techniczna im. Jaroslawa Dabrowskiego (PL) | 1986-02-05 | — | — | EP | disclosed |
| EP-0126883-A1 | Liquid crystalline cyclohexylbenzene derivatives, their preparation and the liquid crystal compositions containing them | Wojskowa Akademia Techniczna im. Jaroslawa Dabrowskiego (PL) | 1984-12-05 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240190866-A1 | POLYHYDROXYLATED INDOLIZIDINE AND PYRROLIZIDINE DERIVATIVES AND USES THEREOF | PHKB, BET1, IDO1 | MEN1 3949/4885MAPK1 4689/4885KMT2A 2447/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.